Myosin binding protein-C limits strain induced cross-bridge detachment in response to rapid stretch in cardiac and skeletal muscle

This study demonstrates that while Myosin binding protein-C (MyBP-C) paralogs share common regulatory functions across muscle types, they exert unique, tissue-specific effects on cross-bridge kinetics—particularly in limiting strain-induced detachment during rapid stretch—to meet the distinct mechanical demands of cardiac and skeletal muscles.

The Gist

The Big Picture: The "Brake and Clutch" of Your Muscles

Imagine your muscles are like a high-performance car engine. To make the car move, you need gas (calcium) and pistons (myosin proteins) that push against the road. But to make the car stop, slow down, or change gears smoothly, you need a brake and a clutch.

In your muscles, there is a family of proteins called Myosin Binding Protein-C (MyBP-C) that acts as this brake and clutch. They are found in your heart, your fast-twitch muscles (like the ones you use to sprint), and your slow-twitch muscles (like the ones you use to stand or walk).

For a long time, scientists thought that because these proteins look very similar in the heart and in skeletal muscles, they probably did the exact same job everywhere. This paper says: "Not so fast!"

The researchers discovered that while these proteins do some of the same basic jobs, they are actually specialized tools tuned specifically for the type of muscle they live in.

---

The Experiment: The "Cut and Paste" Surgery

To figure this out, the scientists used a clever trick they call a "Cut and Paste" strategy.

Imagine you have three different types of cars: a race car (fast muscle), a delivery truck (slow muscle), and a luxury sedan (heart muscle). They all have a specific part in the engine called the "MyBP-C clutch."

The scientists genetically engineered mice so that they could surgically cut out the original clutch from the engine and paste in a clutch from a different type of car.

• They took the fast-muscle clutch and put it into the heart.
• They took the heart clutch and put it into the fast muscle.
• They removed the clutches entirely to see what happened.

What They Found: The Three Main Rules

1. The "Universal Brake" (Common Effects)

No matter which muscle type they were in, all three versions of the MyBP-C protein did three things the same way:

• They made the muscle more sensitive to the "gas pedal" (Calcium): It took less gas to get the muscle moving.
• They slowed down the engine: They made the pistons cycle a bit slower, preventing the engine from revving too wildly.
• They stopped the engine from shaking: Without these proteins, the muscle would start to vibrate or tremble uncontrollably (like a car with a broken suspension). The proteins act like shock absorbers to keep things smooth.

2. The "Stretch Response" (The Big Difference)

This is where the magic happened. The scientists gave the muscles a quick, sharp stretch (like pulling a rubber band) while they were trying to contract.

• The Heart Muscle: When you stretch a heart muscle, it has a unique reaction. It pulls back, dips down a little, and then surges forward with extra force. This is called "Stretch Activation." It's like a spring that, when pulled, snaps back harder than before. This helps the heart fill with blood quickly.
• The Fast Muscle (Sprinters): When you stretch a fast muscle, it usually just relaxes a bit and then settles. It doesn't have that big "surge."

The Discovery:

• When they removed the fast-muscle protein, the sprinting muscle suddenly started acting like a heart muscle. It developed that big "surge" after being stretched.
• When they put the fast-muscle protein into the heart, the heart muscle lost its "surge" and started acting like a sprinter.

The Analogy: It's like swapping the suspension on a race car with the suspension from a luxury sedan. The race car suddenly rides too smoothly and can't handle sharp turns, while the sedan suddenly bounces around too much. The protein dictates how the muscle reacts to being pulled.

3. The "Structural Glue" (Why it happens)

The scientists also looked at the muscle under a giant X-ray microscope. They found that the MyBP-C protein acts like structural glue.

• When the protein is there, the internal parts of the muscle (the thick and thin filaments) are lined up perfectly, like soldiers in a parade.
• When they cut the protein out, the soldiers started to stumble and fall out of line. The "glue" was gone, so the structure got messy. This messiness is what causes the muscle to let go of its grip (detach) too easily when stretched.

Why Does This Matter?

This research changes how we understand muscle diseases.

1. Heart Disease: Mutations in the heart version of this protein cause heart failure. Now we know that the heart needs its specific protein to handle the "stretch" of filling with blood. If you swap it for a skeletal version, the heart can't fill properly.
2. Muscle Tremors: Mutations in the skeletal versions cause muscle tremors. We now know this is because the muscle loses its "shock absorbers" and starts vibrating.
3. Future Treatments: If we want to fix a heart problem, we can't just use any MyBP-C protein. We have to use the heart-specific one. If we want to fix a skeletal muscle problem, we need the skeletal one. They aren't interchangeable.

The Bottom Line

MyBP-C proteins are like specialized tuning forks. They all make a sound (regulate the muscle), but they are tuned to different frequencies. The heart needs a deep, resonant tone to handle blood flow, while the sprinting muscle needs a sharp, quick tone for speed. If you tune the wrong instrument, the whole song falls apart.

Technical Summary

1. Problem Statement

Myosin binding protein-C (MyBP-C) is a family of regulatory proteins found in the sarcomeres of striated muscle, comprising three paralogs: slow skeletal (sMyBP-C), fast skeletal (fMyBP-C), and cardiac (cMyBP-C). While these paralogs share significant structural homology and are encoded by separate genes, it has been assumed they exert similar functional effects across different muscle types. Mutations in any of these paralogs lead to distinct diseases (e.g., hypertrophic cardiomyopathy for cMyBP-C; distal arthrogryposis for skeletal paralogs).

The central problem addressed is whether these paralogs function identically or if they have evolved unique, muscle-type-specific roles. Specifically, the authors sought to determine how the presence or absence of specific MyBP-C paralogs influences:

• Calcium ($Ca^{2+}$) sensitivity of tension.
• Cross-bridge cycling kinetics.
• Strain-induced cross-bridge detachment (a critical mechanism governing the response to rapid muscle stretch, known as "stretch activation" or SA).

2. Methodology

The study utilized a sophisticated "cut and paste" genetic engineering strategy using three distinct lines of gene-edited mice:

• SpyC1: Slow-twitch skeletal muscle (soleus).
• SnoopC2: Fast-twitch skeletal muscle (psoas).
• SpyC3: Cardiac muscle (left ventricle).

Experimental Workflow:

1. Selective Cleavage ("Cut"): Permeabilized muscle fibers were treated with TEV protease (TEVp). These mouse lines contain a TEV protease recognition site inserted between domains C7 and C8 of the MyBP-C gene. TEVp cleavage selectively removes the N-terminal regulatory domains (C0-C7 in cardiac; C1-C7 in skeletal) while leaving the C-terminal anchor (C8-C10) attached to the thick filament.
2. In Situ Replacement ("Paste"): Recombinant MyBP-C proteins (containing a SpyCatcher or SnoopCatcher domain) were added to the fibers. These proteins covalently ligate to the remaining C8 domain, allowing the researchers to replace the endogenous paralog with a different one (e.g., replacing cardiac MyBP-C with fast skeletal MyBP-C) within the same fiber.
3. Mechanical Assays:
   • Isometric Force & $Ca^{2+}$ Sensitivity: Measured tension-pCa curves and cross-bridge cycling rates ($k_{tr}$) via slack-restretch maneuvers.
   • Stretch Activation: Fibers underwent a rapid 2% stretch. The resulting tension transients were analyzed for specific phases: P1 (elastic rise), P2 (relaxation nadir), and P3 (delayed force recovery/SA).
   • Spontaneous Oscillatory Contractions (SPOC): Monitored for force instabilities at submaximal $Ca^{2+}$.
4. Structural Analysis: Small-angle X-ray diffraction was performed on psoas muscle fibers to assess sarcomere lattice order, myosin head orientation, and thin filament length during active contraction.

3. Key Contributions

• Direct Paralog Comparison: This is the first study to systematically remove and swap MyBP-C paralogs in situ within their native muscle environments to isolate the specific mechanical contribution of each paralog, controlling for other variables like myosin isoforms.
• Decoupling Common vs. Unique Functions: The study distinguishes between functions shared by all paralogs (e.g., slowing cross-bridge cycling) and those unique to specific paralogs (e.g., modulating strain-induced detachment).
• Mechanistic Insight into Stretch Activation: The paper identifies MyBP-C as a critical regulator of strain-induced cross-bridge detachment, a mechanism previously thought to be intrinsic to myosin isoforms alone.

4. Key Results

A. Common Functional Effects (Shared by all Paralogs)

• $Ca^{2+}$ Sensitivity: Removal of the N-terminal domains reduced $Ca^{2+}$ sensitivity (rightward shift in pCa50) in cardiac and fast skeletal muscle.
• Cross-Bridge Kinetics: Loss of any MyBP-C paralog increased cross-bridge cycling rates ($k_{tr}$) at submaximal $Ca^{2+}$, indicating faster attachment/detachment.
• Damping Oscillations: Removal of MyBP-C in all muscle types induced Spontaneous Oscillatory Contractions (SPOC) at submaximal $Ca^{2+}$, suggesting MyBP-C is essential for stabilizing sarcomeres and preventing mechanical instability.

B. Unique Effects on Strain-Induced Detachment (The Core Finding)

The response to rapid stretch differed significantly based on the MyBP-C paralog present:

• Cardiac Muscle (cMyBP-C): Exhibits a canonical 3-phase response with a deep P2 nadir and a prominent delayed force recovery (P3/SA). Loss of cMyBP-C modestly increased detachment rates but did not drastically alter the transient shape.
• Fast Skeletal Muscle (fMyBP-C): Typically shows a shallow P2 nadir and minimal SA. Crucially, removing fMyBP-C converted the fast skeletal response into a cardiac-like response: P2 dropped significantly below pre-stretch tension, and a robust delayed force recovery (SA) appeared.
• Swap Experiments:
  • Replacing cMyBP-C in cardiomyocytes with fMyBP-C eliminated the SA response and elevated the P2 nadir, mimicking fast skeletal muscle.
  • Replacing cMyBP-C with sMyBP-C similarly blunted the SA response.
• Conclusion: MyBP-C paralogs actively limit strain-induced cross-bridge detachment. Fast skeletal MyBP-C is particularly potent at suppressing this detachment, preventing the "cardiac-like" SA response.

C. Structural Insights (X-ray Diffraction)

In psoas muscle (fast skeletal) following fMyBP-C removal:

• Lattice Disorder: Increased heterogeneity in lattice spacing ($\sigma_D$), indicating reduced structural integrity.
• Myosin Head Order: The intensity of the M3 reflection ($I_{M3}$) decreased, suggesting increased angular disorder of myosin heads, even though the proportion of heads in the "ON" state (spacing $S_{M3}$) remained unchanged.
• Thin Filament Length: The spacing of actin layer lines (ALL6) and troponin reflections (ST3) decreased, indicating a shortening of the thin filament. This suggests MyBP-C normally exerts a strain on the thin filament to maintain its length and alignment.

5. Significance

• Physiological Adaptation: The findings suggest that MyBP-C paralogs are evolutionarily adapted to meet the mechanical demands of specific muscle types.
  • Cardiac Muscle: Requires rapid relaxation (diastole) to fill the ventricle. MyBP-C facilitates this by allowing controlled strain-induced detachment (SA), ensuring efficient relaxation.
  • Fast Skeletal Muscle: Requires sustained, rapid force generation. fMyBP-C suppresses strain-induced detachment to maintain force stability and prevent premature relaxation during rapid contractions.
• Disease Mechanisms: The study provides a mechanistic basis for why mutations in different MyBP-C paralogs cause distinct pathologies. Loss of the "damping" effect on strain-induced detachment could lead to diastolic dysfunction in the heart or tremors/instability in skeletal muscle (SPOC).
• Therapeutic Implications: Understanding that MyBP-C regulates the "drag" and "reversal" terms of cross-bridge kinetics opens new avenues for targeting specific paralogs to treat muscle diseases without disrupting the global contractile machinery.

In summary, the paper demonstrates that while MyBP-C paralogs share common regulatory roles, they possess unique, paralog-specific capabilities to modulate how cross-bridges respond to mechanical strain, thereby fine-tuning the contractile properties of cardiac versus skeletal muscle.